Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Dopamine and Norepinephrine as the First Vasopressor Agent in the Management of Shock

NCT00314704 is registered in ClinicalTrials.gov with Sepsis Occurrence in Acutely Ill Patients as lead sponsor.

NCT NCT00314704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Dopamine and Norepinephrine as the First Vasopressor Agent in the Management of Shock
Lead sponsor
Sepsis Occurrence in Acutely Ill Patients
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
October 31, 2007
Enrollment
1,679 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

shock